Chinese private equity firm CDH Investments has teamed with China Grand Pharmaceutical & Healthcare to buy a majority stake in contact lens maker Shanghai Weicon Optical.
The $78.7m deal will see the pair pick up just over 71 per cent of the business according to a regulatory filing.
CDH will hold 19 per cent of Shanghai Weicon by parting with $21m, with China Grand Pharma holding the balance of the investment.
The pair have also agreed to invest $15m in the future growth of the company, with $4m of this coming from CDH.
Shanghai Weicon has more than 30 per cent share in the Chinese contact lens market.
Copyright © 2014 AltAssets